BioNexus Gene Lab Corp. (BGLC)

USD 2.69

(-3.5%)

Inventory Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual inventory in 2023 was 1.13 Million USD , up 16.36% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly inventory in 2024 Q2 was 1.03 Million USD , down -4.08% from previous quarter.
  • BioNexus Gene Lab Corp. reported annual inventory of 977.8 Thousand USD in 2022, down -35.75% from previous year.
  • BioNexus Gene Lab Corp. reported annual inventory of 1.52 Million USD in 2021, up 29.4% from previous year.
  • BioNexus Gene Lab Corp. reported quarterly inventory of 1.07 Million USD for 2024 Q1, down -5.35% from previous quarter.
  • BioNexus Gene Lab Corp. reported quarterly inventory of 1.16 Million USD for 2023 Q2, up 29.58% from previous quarter.

Annual Inventory Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Inventory of BioNexus Gene Lab Corp. (2023 - 2016)

Year Inventory Inventory Growth
2023 1.13 Million USD 16.36%
2022 977.8 Thousand USD -35.75%
2021 1.52 Million USD 29.4%
2020 1.17 Million USD 15416.75%
2019 7580.00 USD -50.46%
2018 15.3 Thousand USD -52.31%
2017 32.08 Thousand USD 0.0%
2016 - USD 0.0%

Peer Inventory Comparison of BioNexus Gene Lab Corp.

Name Inventory Inventory Difference
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD -244.751%
Aspira Women's Health Inc. 227 Thousand USD -401.22%
Biodesix, Inc. 1.4 Million USD 18.731%
bioAffinity Technologies, Inc. 18.48 Thousand USD -6055.432%
bioAffinity Technologies, Inc. 18.48 Thousand USD -6055.432%
Bionano Genomics, Inc. 22.89 Million USD 95.03%
CareDx, Inc 19.47 Million USD 94.157%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 7.94 Million USD 85.674%
DarioHealth Corp. 5.06 Million USD 77.523%
Exact Sciences Corporation 127.47 Million USD 99.107%
Fulgent Genetics, Inc. 5.82 Million USD 80.474%
Guardant Health, Inc. 61.94 Million USD 98.163%
ICON Public Limited Company 1.00 USD -113776900.0%
IDEXX Laboratories, Inc. 380.28 Million USD 99.701%
Illumina, Inc. 587 Million USD 99.806%
Intelligent Bio Solutions Inc. 777.53 Thousand USD -46.33%
iSpecimen Inc. - USD -Infinity%
Standard BioTools Inc. 20.53 Million USD 94.459%
MDxHealth SA 2.77 Million USD 59.058%
23andMe Holding Co. 12.46 Million USD 90.872%
Medpace Holdings, Inc. 1.00 USD -113776900.0%
Myriad Genetics, Inc. 20.1 Million USD 94.339%
Mainz Biomed B.V. 613.63 Thousand USD -85.414%
ENDRA Life Sciences Inc. 2.62 Million USD 56.621%
NeoGenomics, Inc. 24.15 Million USD 95.29%
Neogen Corporation 189.26 Million USD 99.399%
Inotiv, Inc. 56.1 Million USD 97.972%
Natera, Inc. 40.75 Million USD 97.209%
OPKO Health, Inc. 65.69 Million USD 98.268%
Psychemedics Corporation 1.00 USD -113776900.0%
Prenetics Global Limited 3.12 Million USD 63.612%
Prenetics Global Limited 3.12 Million USD 63.612%
Precipio, Inc. 384 Thousand USD -196.294%
Personalis, Inc. 5.66 Million USD 79.902%
RadNet, Inc. 1.00 USD -113776900.0%
Sera Prognostics, Inc. - USD -Infinity%
Sotera Health Company 51.98 Million USD 97.811%
Neuronetics, Inc. 8.09 Million USD 85.941%
Star Equity Holdings, Inc. 3.42 Million USD 66.732%
Star Equity Holdings, Inc. 3.42 Million USD 66.732%
Trinity Biotech plc 19.93 Million USD 94.292%
Twist Bioscience Corporation 32.06 Million USD 96.451%
Exagen Inc. 2.87 Million USD 60.37%